Lapthrop wins manufacturing contract for acid analysis system
deltaDOT has awarded Lathrop Engineering the manufacturing contract for its first two commercial products: a protein/nucleic acid analysis system and a DNA sequencer.
deltaDOT has awarded Lathrop Engineering the manufacturing contract for its first two commercial products: a protein/nucleic acid analysis system and a DNA sequencer.
Based on deltaDOT's proprietary biomolecule detection technique, Label Free Intrinsic Imaging (LFII) technology, the Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer offer sensitivity, high-speed throughput and low running costs.
Lathrop, an industrial design and engineering company based in California, US, is ISO 9001 certified and has over 20 years' experience in bioscience manufacturing, which includes the development of biomedical instruments. Advance sales of both units have already been made and the first shipments are expected in December 2005.
LFII is derived from recent innovations in high-energy physics research and their application in modern biochemical analysis. Unlike conventional techniques, the technology does not require target molecules to be labelled, thus improving data quantification, while reducing throughput times, operating costs and health and safety issues.
Founded as a spin-out from Imperial College at the University London, where it is based, deltaDOT specialises in the creation of new biotools for the enhancement of productivity in pharmaceutical and biotechnology research.